APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tourette Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tourette Syndrome Drug Industry Growth and Trends Forecast to 2032

Report ID 174042330122 December 202597 pages

Choose your research edition.

Industry ResearchTourette Syndrome Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Tourette Syndrome Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Tourette Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tourette Syndrome Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tourette Syndrome Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Tourette Syndrome Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tourette Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tourette Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tourette Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tourette Syndrome Drug include Teva Pharmaceutical Industries Ltd, Therapix Biosciences Ltd, Synchroneuron Inc, Reviva Pharmaceuticals Inc, Psyadon Pharmaceuticals Inc, Neurocrine Biosciences Inc, Catalyst Pharmaceuticals Inc and Abide Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tourette Syndrome Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tourette Syndrome Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tourette Syndrome Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tourette Syndrome Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tourette Syndrome Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tourette Syndrome Drug Market by Company

Teva Pharmaceutical Industries Ltd

Therapix Biosciences Ltd

Synchroneuron Inc

Reviva Pharmaceuticals Inc

Psyadon Pharmaceuticals Inc

Neurocrine Biosciences Inc

Catalyst Pharmaceuticals Inc

Abide Therapeutics Inc

Tourette Syndrome Drug Segment by Type

Ecopipam Hydrochloride

Dutetrabenazine ER

CPP-115

AZD-5213

Others

Tourette Syndrome Drug Segment by Application

Clinic

Hospital

Research Center

Others

Tourette Syndrome Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tourette Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tourette Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tourette Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tourette Syndrome Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tourette Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ecopipam Hydrochloride Table 2. Major Company of Dutetrabenazine ER Table 3. Major Company of CPP-115 Table 4. Major Company of AZD-5213 Table 5. Major Company of Others Table 6. Global Tourette Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 8. Global Tourette Syndrome Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Tourette Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Tourette Syndrome Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Tourette Syndrome Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 13. Global Tourette Syndrome Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Tourette Syndrome Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Tourette Syndrome Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Tourette Syndrome Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 18. North America Tourette Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Tourette Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Tourette Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Tourette Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Tourette Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Tourette Syndrome Drug Industry Trends Table 28. Tourette Syndrome Drug Industry Drivers Table 29. Tourette Syndrome Drug Industry Opportunities and Challenges Table 30. Tourette Syndrome Drug Industry Restraints Table 31. Global Tourette Syndrome Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Tourette Syndrome Drug Revenue Market Share by Company (2021-2026) Table 33. Global Tourette Syndrome Drug Sales by Company (2021-2026) & (k units) Table 34. Global Tourette Syndrome Drug Sales Share by Company (2021-2026) Table 35. Global Tourette Syndrome Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Tourette Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Tourette Syndrome Drug Major Company Production Sites and Headquarters Table 38. Global Tourette Syndrome Drug Company, Product Type & Application Table 39. Global Tourette Syndrome Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Tourette Syndrome Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Tourette Syndrome Drug Sales by Region (2021-2026) & (k units) Table 44. Global Tourette Syndrome Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Tourette Syndrome Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Tourette Syndrome Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Tourette Syndrome Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Tourette Syndrome Drug Sales by Region (2027-2032) & (k units) Table 49. Global Tourette Syndrome Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Tourette Syndrome Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Tourette Syndrome Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Tourette Syndrome Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Tourette Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 55. Global Tourette Syndrome Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Tourette Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Tourette Syndrome Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Tourette Syndrome Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 60. Global Tourette Syndrome Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Tourette Syndrome Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Tourette Syndrome Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Tourette Syndrome Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 65. North America Tourette Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Tourette Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Tourette Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Tourette Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Tourette Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Pharmaceutical Industries Ltd Company Information Table 75. Teva Pharmaceutical Industries Ltd Business Overview Table 76. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio Table 78. Teva Pharmaceutical Industries Ltd Recent Development Table 79. Therapix Biosciences Ltd Company Information Table 80. Therapix Biosciences Ltd Business Overview Table 81. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio Table 83. Therapix Biosciences Ltd Recent Development Table 84. Synchroneuron Inc Company Information Table 85. Synchroneuron Inc Business Overview Table 86. Synchroneuron Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Synchroneuron Inc Tourette Syndrome Drug Product Portfolio Table 88. Synchroneuron Inc Recent Development Table 89. Reviva Pharmaceuticals Inc Company Information Table 90. Reviva Pharmaceuticals Inc Business Overview Table 91. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 93. Reviva Pharmaceuticals Inc Recent Development Table 94. Psyadon Pharmaceuticals Inc Company Information Table 95. Psyadon Pharmaceuticals Inc Business Overview Table 96. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 98. Psyadon Pharmaceuticals Inc Recent Development Table 99. Neurocrine Biosciences Inc Company Information Table 100. Neurocrine Biosciences Inc Business Overview Table 101. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio Table 103. Neurocrine Biosciences Inc Recent Development Table 104. Catalyst Pharmaceuticals Inc Company Information Table 105. Catalyst Pharmaceuticals Inc Business Overview Table 106. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 108. Catalyst Pharmaceuticals Inc Recent Development Table 109. Abide Therapeutics Inc Company Information Table 110. Abide Therapeutics Inc Business Overview Table 111. Abide Therapeutics Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio Table 113. Abide Therapeutics Inc Recent Development Table 114. North America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. North America Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 116. North America Tourette Syndrome Drug Sales Market Share by Country (2021-2026) Table 117. North America Tourette Syndrome Drug Sales Forecast by Country (2027-2032) & (k units) Table 118. North America Tourette Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 119. North America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Tourette Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Tourette Syndrome Drug Market Share by Country (2021-2026) Table 122. North America Tourette Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Tourette Syndrome Drug Market Share Forecast by Country (2027-2032) Table 124. Europe Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Europe Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 126. Europe Tourette Syndrome Drug Sales Market Share by Country (2021-2026) Table 127. Europe Tourette Syndrome Drug Sales Forecast by Country (2027-2032) & (k units) Table 128. Europe Tourette Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Tourette Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Tourette Syndrome Drug Market Share by Country (2021-2026) Table 132. Europe Tourette Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Tourette Syndrome Drug Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 136. Asia-Pacific Tourette Syndrome Drug Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Tourette Syndrome Drug Sales Forecast by Country (2027-2032) & (k units) Table 138. Asia-Pacific Tourette Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Tourette Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Tourette Syndrome Drug Market Share by Country (2021-2026) Table 142. Asia-Pacific Tourette Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Tourette Syndrome Drug Market Share Forecast by Country (2027-2032) Table 144. Latin America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Latin America Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 146. Latin America Tourette Syndrome Drug Sales Market Share by Country (2021-2026) Table 147. Latin America Tourette Syndrome Drug Sales Forecast by Country (2027-2032) & (k units) Table 148. Latin America Tourette Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Tourette Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Tourette Syndrome Drug Market Share by Country (2021-2026) Table 152. Latin America Tourette Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Tourette Syndrome Drug Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 156. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Tourette Syndrome Drug Sales Forecast by Country (2027-2032) & (k units) Table 158. Middle East and Africa Tourette Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Tourette Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Tourette Syndrome Drug Market Share by Country (2021-2026) Table 162. Middle East and Africa Tourette Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Tourette Syndrome Drug Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Tourette Syndrome Drug Distributors List Table 167. Tourette Syndrome Drug Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Tourette Syndrome Drug Image Figure 2. Global Tourette Syndrome Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tourette Syndrome Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Tourette Syndrome Drug Sales (2021-2032) & (k units) Figure 5. Ecopipam Hydrochloride Image Figure 6. Global Ecopipam Hydrochloride Sales YoY Growth (2021-2032) & (k units) Figure 7. Dutetrabenazine ER Image Figure 8. Global Dutetrabenazine ER Sales YoY Growth (2021-2032) & (k units) Figure 9. CPP-115 Image Figure 10. Global CPP-115 Sales YoY Growth (2021-2032) & (k units) Figure 11. AZD-5213 Image Figure 12. Global AZD-5213 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Tourette Syndrome Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Tourette Syndrome Drug Market Share by Type 2025 VS 2032 Figure 17. North America Tourette Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Tourette Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Tourette Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Tourette Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Tourette Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Tourette Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Tourette Syndrome Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Research Center Image Figure 34. Global Research Center Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Tourette Syndrome Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Tourette Syndrome Drug Market Share by Application 2025 VS 2032 Figure 39. North America Tourette Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Tourette Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Tourette Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Tourette Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Tourette Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Tourette Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Tourette Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Tourette Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Tourette Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Tourette Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Tourette Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Tourette Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Tourette Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Tourette Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Tourette Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Tourette Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Tourette Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Tourette Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Tourette Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Tourette Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Tourette Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Tourette Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Tourette Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Tourette Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Tourette Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Tourette Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Tourette Syndrome Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Tourette Syndrome Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Ecopipam Hydrochloride
  • Dutetrabenazine ER
  • CPP-115
  • AZD-5213
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Therapix Biosciences Ltd
  • Synchroneuron Inc
  • Reviva Pharmaceuticals Inc
  • Psyadon Pharmaceuticals Inc
  • Neurocrine Biosciences Inc
  • Catalyst Pharmaceuticals Inc
  • Abide Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tourette Syndrome Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tourette Syndrome Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tourette Syndrome Drug Market by Type
  6. 1.3.1 Ecopipam Hydrochloride
  7. 1.3.2 Dutetrabenazine ER
  8. 1.3.3 CPP-115
  9. 1.3.4 AZD-5213
  10. 1.3.5 Others
  11. 1.4 Global Tourette Syndrome Drug Market Size by Type
  12. 1.4.1 Global Tourette Syndrome Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Tourette Syndrome Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Tourette Syndrome Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Tourette Syndrome Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Tourette Syndrome Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Tourette Syndrome Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Tourette Syndrome Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Tourette Syndrome Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tourette Syndrome Drug Industry Trends
  2. 2.2 Tourette Syndrome Drug Industry Drivers
  3. 2.3 Tourette Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Tourette Syndrome Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tourette Syndrome Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Tourette Syndrome Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Tourette Syndrome Drug Price (2021-2026)
  4. 3.4 Global Tourette Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tourette Syndrome Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Tourette Syndrome Drug Company, Product Type & Application
  7. 3.7 Global Tourette Syndrome Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tourette Syndrome Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tourette Syndrome Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tourette Syndrome Drug Tier 1, Tier 2, and Tier 3
4 Tourette Syndrome Drug Regional Status and Outlook
  1. 4.1 Global Tourette Syndrome Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tourette Syndrome Drug Historic Market Size by Region
  3. 4.2.1 Global Tourette Syndrome Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tourette Syndrome Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tourette Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tourette Syndrome Drug Forecasted Market Size by Region
  7. 4.3.1 Global Tourette Syndrome Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tourette Syndrome Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tourette Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tourette Syndrome Drug by Application
  1. 5.1 Tourette Syndrome Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Research Center
  5. 5.1.4 Others
  6. 5.2 Global Tourette Syndrome Drug Market Size by Application
  7. 5.2.1 Global Tourette Syndrome Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Tourette Syndrome Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Tourette Syndrome Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Tourette Syndrome Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Tourette Syndrome Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Tourette Syndrome Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Tourette Syndrome Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Tourette Syndrome Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries Ltd
  2. 6.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 6.2 Therapix Biosciences Ltd
  8. 6.2.1 Therapix Biosciences Ltd Company Information
  9. 6.2.2 Therapix Biosciences Ltd Business Overview
  10. 6.2.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio
  12. 6.2.5 Therapix Biosciences Ltd Recent Developments
  13. 6.3 Synchroneuron Inc
  14. 6.3.1 Synchroneuron Inc Company Information
  15. 6.3.2 Synchroneuron Inc Business Overview
  16. 6.3.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Synchroneuron Inc Tourette Syndrome Drug Product Portfolio
  18. 6.3.5 Synchroneuron Inc Recent Developments
  19. 6.4 Reviva Pharmaceuticals Inc
  20. 6.4.1 Reviva Pharmaceuticals Inc Company Information
  21. 6.4.2 Reviva Pharmaceuticals Inc Business Overview
  22. 6.4.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  24. 6.4.5 Reviva Pharmaceuticals Inc Recent Developments
  25. 6.5 Psyadon Pharmaceuticals Inc
  26. 6.5.1 Psyadon Pharmaceuticals Inc Company Information
  27. 6.5.2 Psyadon Pharmaceuticals Inc Business Overview
  28. 6.5.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  30. 6.5.5 Psyadon Pharmaceuticals Inc Recent Developments
  31. 6.6 Neurocrine Biosciences Inc
  32. 6.6.1 Neurocrine Biosciences Inc Company Information
  33. 6.6.2 Neurocrine Biosciences Inc Business Overview
  34. 6.6.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio
  36. 6.6.5 Neurocrine Biosciences Inc Recent Developments
  37. 6.7 Catalyst Pharmaceuticals Inc
  38. 6.7.1 Catalyst Pharmaceuticals Inc Company Information
  39. 6.7.2 Catalyst Pharmaceuticals Inc Business Overview
  40. 6.7.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  42. 6.7.5 Catalyst Pharmaceuticals Inc Recent Developments
  43. 6.8 Abide Therapeutics Inc
  44. 6.8.1 Abide Therapeutics Inc Company Information
  45. 6.8.2 Abide Therapeutics Inc Business Overview
  46. 6.8.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio
  48. 6.8.5 Abide Therapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Tourette Syndrome Drug Sales by Country
  2. 7.1.1 North America Tourette Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tourette Syndrome Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Tourette Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tourette Syndrome Drug Market Size by Country
  6. 7.2.1 North America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tourette Syndrome Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Tourette Syndrome Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tourette Syndrome Drug Sales by Country
  2. 8.1.1 Europe Tourette Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tourette Syndrome Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Tourette Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tourette Syndrome Drug Market Size by Country
  6. 8.2.1 Europe Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tourette Syndrome Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tourette Syndrome Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tourette Syndrome Drug Sales by Country
  2. 9.1.1 Asia-Pacific Tourette Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tourette Syndrome Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tourette Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tourette Syndrome Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tourette Syndrome Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tourette Syndrome Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tourette Syndrome Drug Sales by Country
  2. 10.1.1 South America Tourette Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tourette Syndrome Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Tourette Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tourette Syndrome Drug Market Size by Country
  6. 10.2.1 South America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tourette Syndrome Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Tourette Syndrome Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tourette Syndrome Drug Sales by Country
  2. 11.1.1 Middle East and Africa Tourette Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tourette Syndrome Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tourette Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tourette Syndrome Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tourette Syndrome Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tourette Syndrome Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tourette Syndrome Drug Value Chain Analysis
  2. 12.1.1 Tourette Syndrome Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tourette Syndrome Drug Production Mode & Process
  7. 12.2 Tourette Syndrome Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tourette Syndrome Drug Distributors
  10. 12.2.3 Tourette Syndrome Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst